Portfolio

Carmel's 'SMART' Drug Product Development Platform

Intellectual property that focuses on the reformulation of approved drugs.

CAR-501 - PREXXARTAN™ Valsartan Oral Solution, 4 mg/mL (NDA Approval Dec. 2017)

CAR-503 and CAR-504 Projects

CAR-505, CAR-506, CAR-507, and CAR-508 Projects

CAR-509, CAR-510, CAR-511, and CAR-512 Projects